SEC Form 4 · accession 0000899243-18-031271
Adicet Bio, Inc. · ACET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joan Mannick
Officer — Chief Medical Officer
Period of report
Oct 26, 2018
Accepted (ET)
Dec 17, 2018 · 9:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001720580
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 26, 2018 | G | 600,000 | $0.00 | D | 1,286,363 | D | |
| Common StockF1 | Oct 26, 2018 | G | 600,000 | $0.00 | A | 600,000 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On October 26, 2018, the reporting person transferred 600,000 shares of common stock to the J.B. Mannick Irrevocable Trust (the "Trust"). The reporting person disclaims Section 16 beneficial ownership of these shares except to the extent, if any, of the reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose. On July 23, 2018, the reporting person transferred 600,000 shares to a grantor retained annuity trust, which shares are included in the reporting person's direct ownership. Following this transfer, the reporting person directly held 1,286,363 shares and the Trust directly held 600,000 shares.